MiR-760 overexpression promotes proliferation in ovarian cancer by downregulation of PHLPP2 expression (Q38741699)

6 September 2017

title

MiR-760 overexpression promotes proliferation in ovarian cancer by downregulation of PHLPP2 expression (English)

1 reference

6 September 2017

1 reference

1 reference

Yanbin Liao

1 reference

6 September 2017

Yalan Deng

1 reference

6 September 2017

Jun Liu

1 reference

6 September 2017

Zhanying Ye

1 reference

6 September 2017

Zeshan You

1 reference

6 September 2017

Shuzhong Yao

1 reference

6 September 2017

Shanyang He

1 reference

6 September 2017

language of work or name

English

0 references

publication date

7 October 2016

1 reference

6 September 2017

1 reference

6 September 2017

volume

143

1 reference

6 September 2017

1 reference

6 September 2017

page(s)

655-663

1 reference

Global cancer statistics, 2012

6 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.09.010

Surgical technique of en bloc pelvic resection for advanced ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.09.010

Trends in relative survival for ovarian cancer from 1975 to 2011.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.09.010

Ovarian cancer screening in the general population: current status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.09.010

Impact of obesity on surgical and oncologic outcomes in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.09.010

Trials show delayed recurrence in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.09.010

Ovarian cancer: sites of recurrence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.09.010

MicroRNAs: genomics, biogenesis, mechanism, and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.09.010

The functions of animal microRNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.09.010

MicroRNAs and ovarian function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.09.010

Regulatory role of microRNAs in ovarian function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.09.010

MicroRNAs in ovarian function and disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.09.010

MiR-34a suppresses ovarian cancer proliferation and motility by targeting AXL.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.09.010

MiR-23b targets cyclin G1 and suppresses ovarian cancer tumorigenesis and progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.09.010

MicroRNA-17 promotes normal ovarian cancer cells to cancer stem cells development via suppression of the LKB1-p53-p21/WAF1 pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.09.010

PHLPP2 Downregulation Contributes to Lung Carcinogenesis Following B[a]P/B[a]PDE Exposure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.09.010

Mutation profiling identifies numerous rare drug targets and distinct mutation patterns in different clinical subtypes of breast cancers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.09.010

miR-205 targets PTEN and PHLPP2 to augment AKT signaling and drive malignant phenotypes in non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.09.010

microRNA-224 promotes cell proliferation and tumor growth in human colorectal cancer by repressing PHLPP1 and PHLPP2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.09.010

The phosphatase PHLPP1 regulates Akt2, promotes pancreatic cancer cell death, and inhibits tumor formation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.09.010

Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.09.010

Missing link between microRNA and prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.09.010

The diverse functions of microRNAs in animal development and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.09.010

MicroRNAs in cancer: biomarkers, functions and therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.09.010

Serum microRNAs: A new diagnostic method for colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.09.010

Contrasting expression patterns of histone mRNA and microRNA 760 in patients with gastric cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.09.010

Systematic analysis of gene expression pattern in has-miR-760 overexpressed resistance of the MCF-7 human breast cancer cell to doxorubicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.09.010

Upregulation of miR-760 and miR-186 is associated with replicative senescence in human lung fibroblast cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.09.010

Turning off AKT: PHLPP as a drug target

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.09.010

Photoreceptor Neuroprotection: Regulation of Akt Activation Through Serine/Threonine Phosphatases, PHLPP and PHLPPL.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.09.010

Increased levels of the Akt-specific phosphatase PH domain leucine-rich repeat protein phosphatase (PHLPP)-1 in obese participants are associated with insulin resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.09.010

Serine/threonine kinase akt activation regulates the activity of retinal serine/threonine phosphatases, PHLPP and PHLPPL

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.09.010

AKT signaling in normal and malignant cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.09.010

Tocotrienols target PI3K/Akt signaling in anti-breast cancer therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.09.010

PI3K/AKT and mTOR/p70S6K1 signaling pathways in human cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.09.010

PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.09.010

PHLPP negatively regulates cell motility through inhibition of Akt activity and integrin expression in pancreatic cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.09.010

High PHLPP expression is associated with better prognosis in patients with resected lung adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.09.010

10.1016/J.YGYNO.2016.09.010

7 January 2021

Identifiers

DOI

1 reference

6 September 2017

1 reference